Effectiveness of Theta Burst Stimulation For Upper and Lower Extremity Recovery in Stroke
NCT: NCT07834333 · RECRUITING
Brief Summary
This single-center, single-blind, randomized, sham-controlled clinical trial will include 60 patients aged \>45 years who are within 3 months of a first-ever middle cerebral artery ischemic stroke. Participants will be randomized into four groups: coupled TBS (contralesional cTBS followed by ipsilesional iTBS), cTBS plus sham iTBS, sham cTBS plus iTBS, or sham TBS. TBS will be delivered over the primary motor cortex for 10 sessions over 2 weeks. Stimulation intensity will be set at 80% of the resting motor threshold determined using EMG-guided motor evoked potentials. Each cTBS and iTBS application will consist of 600 pulses. All participants will additionally receive standardized conventional rehabilitation for at least 4 weeks. The primary outcome will be upper-extremity motor recovery assessed using the motor domain of the Fugl-Meyer Assessment. Secondary outcomes will include lower-extremity motor recovery, spasticity, sensory function, cortical excitability, functional ambulation, activities of daily living, and stroke-specific quality of life. Assessments will be performed at baseline, after the 2-week intervention, and at 1-month post-treatment follow-up.
Frequently Asked Questions
What is Effectiveness of Theta Burst Stimulation For Upper and Lower Extremity Recovery in Stroke?
Effectiveness of Theta Burst Stimulation For Upper and Lower Extremity Recovery in Stroke is a clinical trial registered under NCT07834333. Current status: RECRUITING.
What is the status of NCT07834333?
The current status of NCT07834333 (Effectiveness of Theta Burst Stimulation For Upper and Lower Extremity Recovery in Stroke) is: RECRUITING.
When did Effectiveness of Theta Burst Stimulation For Upper and Lower Extremity Recovery in Stroke start?
Effectiveness of Theta Burst Stimulation For Upper and Lower Extremity Recovery in Stroke started on 2026-09-30.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.